| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MGNI | Common Stock | Options Exercise | $41.9K | +5.41K | +2.09% | $7.74 | 264K | Sep 8, 2021 | Direct | |
| transaction | MGNI | Common Stock | Options Exercise | $158K | +28.9K | +10.94% | $5.46 | 293K | Sep 8, 2021 | Direct | |
| transaction | MGNI | Common Stock | Options Exercise | $5.1K | +965 | +0.33% | $5.28 | 294K | Sep 10, 2021 | Direct | |
| transaction | MGNI | Common Stock | Options Exercise | $29.8K | +8.26K | +2.81% | $3.61 | 302K | Sep 10, 2021 | Direct | |
| transaction | MGNI | Common Stock | Options Exercise | $23.6K | +4.58K | +1.52% | $5.16 | 306K | Sep 10, 2021 | Direct | |
| transaction | MGNI | Common Stock | Sale | -$1.21M | -40K | -13.05% | $30.21 | 266K | Sep 10, 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MGNI | Stock Option (Right to Buy) | Options Exercise | $0 | -5.41K | -100% | $0.00* | 0 | Sep 8, 2021 | Common Stock | 5.41K | $7.74 | Direct | F2, F3 |
| transaction | MGNI | Stock Option (Right to Buy) | Options Exercise | $0 | -28.9K | -100% | $0.00* | 0 | Sep 8, 2021 | Common Stock | 28.9K | $5.46 | Direct | F2, F3 |
| transaction | MGNI | Stock Option (Right to Buy) | Options Exercise | $0 | -965 | -3.13% | $0.00 | 29.9K | Sep 10, 2021 | Common Stock | 965 | $5.28 | Direct | F3, F4 |
| transaction | MGNI | Stock Option (Right to Buy) | Options Exercise | $0 | -8.26K | -18.95% | $0.00 | 35.3K | Sep 10, 2021 | Common Stock | 8.26K | $3.61 | Direct | F3, F5 |
| transaction | MGNI | Stock Option (Right to Buy) | Options Exercise | $0 | -4.58K | -16.67% | $0.00 | 22.9K | Sep 10, 2021 | Common Stock | 4.58K | $5.16 | Direct | F3, F6 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.15 to $30.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | This option is fully vested and immediately exercisable. |
| F3 | Equity grant under the Company's 2014 Equity Incentive Plan. |
| F4 | 25% of the total number of shares underlying this option vested on April 1, 2021 and the remaining shares vest 1/36 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date. This equity grant may be subject to accelerated vesting in the event the Reporting Person's employment is terminated under certain circumstances. |
| F5 | 25% of the total number of shares underlying this option vested on February 14, 2019 and the remaining shares vest 1/36 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date. This equity grant may be subject to accelerated vesting in the event the Reporting Person's employment is terminated under certain circumstances. |
| F6 | 25% of the total number of shares underlying this option vested on February 14, 2020 and the remaining shares vest 1/36 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date. This equity grant may be subject to accelerated vesting in the event the Reporting Person's employment is terminated under certain circumstances. |